IL-10 and the resolution of infections

Journal of Pathology

Volumn 214, Issue 2, 2008, Pages 224-230

  Filippi, C M ^a   Von Herrath, M G ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Chronic viral infection; Hepatitis C virus (HCV); Human immune deficiency virus (HIV); Immune suppression; Interleukin 10 (IL 10); Lymphocytic choriomeningitis virus (LCMV); Programmed death 1 (PD 1); Virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN; PERFORIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; LEISHMANIASIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

ANTIVIRAL AGENTS; CHRONIC DISEASE; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; T-LYMPHOCYTES, REGULATORY; VIRUS DISEASES;

EID: 38549141719     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2272     Document Type: Review

References (80)

1. Taieb J, Chaput N, Menard C, Apetoh L, Ullrich E, Bonmort M, et al. A novel dendritic cell subset involved in tumour immunosurveillance. Nat Med 2006;12(2):214-219.
2. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006;354(21):2235-2249.
3. Subramanian C, Cotter MA, 2nd, Robertson ES. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 2001;7(3):350-355.
4. Evans AS, Mueller NE. Viruses and cancer. Causal associations. Ann Epidemiol 1990;1(1):71-92.
5. Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001;98(6):1667-1677.
6. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338(13):853-860.
7. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, et al. Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351(5):438-450.
8. Kamar N, Boulestin A, Selves J, Esposito L, Sandres-Saune K, Stebenet M, et al. Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C. J Med Virol 2005;76(1):61-68.
9. Razvi ES, Welsh RM. Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol 1993;67(10):5754-5765.
10. Rouse BT, Horohov DW. Immunosuppression in viral infections. Rev Infect Dis 1986;8(6):850-873.
11. Burnet FM. The general pathology of virus infections. Lancet 1950;1(23):1059-1063.
12. Fraser NW, Spivack JG, Wroblewska Z, Block T, Deshmane SL, Valyi-Nagy T, et al. A review of the molecular mechanism of HSV-1 latency. Curr Eye Res 1991;10:(suppl): 1-13.
13. Redpath S, Angulo A, Gascoigne NR, Ghazal P. Immune checkpoints in viral latency. Annu Rev Microbiol 2001;55531-55560.
14. Tortorella D, Gewurz B, Schust D, Furman M, Ploegh H. Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumour immunology. Immunol Invest 2000;29(2):97-100.
15. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362(6422):758-761.
16. Zinkernagel RM, Doherty PC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974;248(450):701-702.
17. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996;272(5258):54-60.
18. + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 1994;24(12):3068- 3072.
19. Selin LK, Welsh RM. Specificity and editing by apoptosis of virus-induced cytotoxic T lymphocytes. Curr Opin Immunol 1994;6(4):553-559.
20. Bachmann MF, Barner M, Viola A, Kopf M. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999;29(1):291-299.
21. + T cells during viral infection: correlation with stable memory development. J Gen Virol 2002;83(9):2123-2133.
22. + T cells and non-specific bone marrow-derived cells. J Virol 1987;61(12):3930-3937.
23. Moskophidis D, Assmann-Wischer U, Simon MM, Lehmann-Grube F. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection. Eur J Immunol 1987;17(7):937-942.
24. Zinkernagel RM, Welsh RM. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J Immunol 1976;117(5, pt 1):1495-1502.
25. Oldstone MB, Blount P, Southern PJ, Lampert PW. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature 1986;321(6067):239-243.
26. Ahmed R, Hahn CS, Somasundaram T, Villarete L, Matloubian M, Strauss JH. Molecular basis of organ-specific selection of viral variants during chronic infection. J Virol 1991;65(8):4242-4247.
27. Salvato M, Borrow P, Shimomaye E, Oldstone MB. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 1991;65(4):1863-1869.
28. -). Virology 1988;164(2):517-522.
29. Matloubian M, Somasundaram T, Kolhekar SR, Selvakumar R, Ahmed R. Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. J Exp Med 1990;172(4):1043-1048.
30. Dockter J, Evans CF, Tishon A, Oldstone MB. Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J Virol 1996;70(3):1799-1803.
31. + T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113(7):963-972.
32. Woitas RP, Petersen U, Moshage D, Brackmann HH, Matz B, Sauerbruch T, et al. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J Gastroenterol 2002;8(3):562-566.
33. Ameglio F, Cordiali Fei P, Solmone M, Bonifati C, Prignano G, Giglio A, et al. Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents 1994;8(2):48-52.
34. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93(2):768-775.
35. Orandle MS, Williams KC, MacLean AG, Westmoreland SV, Lackner AA. Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues. J Virol 2001;75(9):4448-4452.
36. Swaminathan S. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Semin Hematol 2003;40(2):107-115.
37. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11165-11190.
38. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19683-19765.
39. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22929-22979.
40. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150(11):4754-4765.
41. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146(10):3444-3451.
42. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991;174(4):915- 924.
43. Granelli-Piperno A, Golebiowska A. Trumpfheller C, Siegal FP, Steinman RM. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc Natl Acad Sci USA 2004;101(20):7669-7674.
44. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248(4960):1230-1234.
45. Nelson DR, Tu Z, Soldevila-Pico C, Abdelmalek M, Zhu H, Xu YL, et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 2003;38(4):859- 868.
46. Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, et al. Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun 2005;6(4):347-357.
47. Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, et al. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 1993;92(1): 324-329.
48. Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG. Restoration of IFN-γ production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 1994;152(12):5949-5956.
49. Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001;194(10):1497- 1506.
50. Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, Crotty S, et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006;203(11):2461-2472.
51. Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006;12(11):1301-1309.
52. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002;3(8):756-763.
53. + suppressor T cells. Immunol Rev 2001;182:58-67.
54. + regulatory T cells. Nat Immunol 2003;4(4):330-336.
55. + T regulatory cells. Nat Immunol 2003;4(4):337-342.
56. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389(6652):737-742.
57. + regulatory T cells at the single-cell level. Eur J Immunol 2005;35(6):1681-1691.
58. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392(6673):245-252.
59. + T cells by exogenous cell-associated antigens. Immunity 2002;17(2):211-220.
60. Probst HC, van den Broek M. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J Immunol 2005;174(7):3920-3924.
61. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5(8):919- 923.
62. Henri S, Vremec D, Kamath A, Waithman J, Williams S, Benoist C, et al. The dendritic cell populations of mouse lymph nodes. J Immunol 2001;167(2):741-748.
63. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999;189(3):587-592.
64. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999;96(3): 1036-1041.
65. - dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 2001;167(8):4345- 4350.
66. Sato M, Chamoto K, Nishimura T. A novel tumour-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells. Int Immunol 2003;15(7):837-843.
67. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003;18(5):605-617.
68. Burkhart C, Liu GY, Anderton SM, Metzler B, Wraith DC. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int Immunol 1999;11(10):1625-1634.
69. + T cells resulting in a failure to lyse tumour cells. Blood 1999;93(5):1634-1642.
70. Alpan O, Bachelder E, Isil E, Arnheiter H, Matzinger P. 'Educated' dendritic cells act as messengers from memory to naive T helper cells. Nat Immunol 2004;5(6):615-622.
71. Visco C, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, et al. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy. Leuk Lymphoma 2004;45(10):2085-2092.
72. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992;11(11):3887-3895.
73. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002;2(2):116-126.
74. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4(5):336-347.
75. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439(7077):682-687.
76. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006;80(22):11398- 11403.
77. Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 2007;81(6):2545-2553.
78. + T cells associated with reversible immune dysfunction. J Virol 2007;81(17):9249-9258.
79. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443(7109):350-354.
80. + T cells leads to reversible immune dysfunction. Nat Med 2006;12(10):1198-1202.